CORSINI, Lidia Rita
 Distribuzione geografica
Continente #
NA - Nord America 3.689
EU - Europa 2.230
AS - Asia 1.855
SA - Sud America 297
AF - Africa 57
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 8.134
Nazione #
US - Stati Uniti d'America 3.622
SG - Singapore 735
RU - Federazione Russa 677
CN - Cina 460
IT - Italia 427
FI - Finlandia 312
BR - Brasile 241
DE - Germania 231
HK - Hong Kong 205
VN - Vietnam 154
GB - Regno Unito 107
PL - Polonia 104
FR - Francia 101
UA - Ucraina 82
JP - Giappone 60
IN - India 48
IE - Irlanda 44
BD - Bangladesh 36
CA - Canada 35
KR - Corea 33
SE - Svezia 32
RO - Romania 26
IQ - Iraq 24
NL - Olanda 22
TR - Turchia 22
MX - Messico 21
BE - Belgio 18
AR - Argentina 16
AT - Austria 16
ZA - Sudafrica 16
CI - Costa d'Avorio 11
VE - Venezuela 10
ES - Italia 9
IR - Iran 9
MA - Marocco 9
CO - Colombia 8
PK - Pakistan 8
EC - Ecuador 7
ID - Indonesia 7
AE - Emirati Arabi Uniti 6
NP - Nepal 6
UZ - Uzbekistan 6
CZ - Repubblica Ceca 5
DZ - Algeria 5
PH - Filippine 5
AZ - Azerbaigian 4
CH - Svizzera 4
EG - Egitto 4
KE - Kenya 4
KZ - Kazakistan 4
MY - Malesia 4
PY - Paraguay 4
UY - Uruguay 4
AU - Australia 3
BO - Bolivia 3
CL - Cile 3
GA - Gabon 3
GE - Georgia 3
GR - Grecia 3
KG - Kirghizistan 3
LT - Lituania 3
PA - Panama 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
BG - Bulgaria 2
CY - Cipro 2
DK - Danimarca 2
EU - Europa 2
IL - Israele 2
AL - Albania 1
AM - Armenia 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GD - Grenada 1
GT - Guatemala 1
LK - Sri Lanka 1
MM - Myanmar 1
MN - Mongolia 1
PE - Perù 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TG - Togo 1
TH - Thailandia 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.134
Città #
Ashburn 574
Singapore 443
Fairfield 313
Chandler 278
Hong Kong 189
San Jose 186
Woodbridge 184
Ann Arbor 153
Moscow 126
Seattle 125
Wilmington 118
Houston 114
Palermo 114
Cambridge 107
Zgierz 86
Los Angeles 85
Helsinki 77
Beijing 76
Council Bluffs 75
New York 73
The Dalles 65
Rome 64
Medford 58
Santa Clara 58
Dallas 56
Tokyo 56
Frankfurt am Main 46
Des Moines 45
Altamura 42
Dublin 42
Ho Chi Minh City 42
Lauterbourg 42
Hanoi 40
Jacksonville 39
Chicago 36
Hefei 34
Princeton 34
Boardman 32
Lawrence 32
Nanjing 29
São Paulo 28
San Diego 27
Dearborn 23
Milan 23
Orem 23
Ludwigshafen am Rhein 21
Buffalo 20
London 20
Brussels 18
Jinan 18
Phoenix 16
Bremen 15
Warsaw 15
Atlanta 14
Denver 14
Johannesburg 14
Nuremberg 14
Seoul 14
Nanchang 13
Tulsa 13
Falls Church 12
Abidjan 11
Changsha 11
Munich 11
Guangzhou 10
Hebei 10
Poplar 10
Shenyang 10
Stockholm 10
Tianjin 10
Amsterdam 9
Chennai 9
Kumar 9
Montreal 9
Mumbai 9
Toronto 9
Venice 9
Baghdad 8
Lappeenranta 8
Manchester 8
Turku 8
Ankara 7
Boston 7
Brasília 7
Brooklyn 7
Columbus 7
Da Nang 7
Kitzingen 7
Tappahannock 7
Bexley 6
Changzhou 6
Haiphong 6
Izmir 6
Kilburn 6
Ottawa 6
Paris 6
Pune 6
San Francisco 6
Taiyuan 6
Tehran 6
Totale 5.073
Nome #
Analysis of molecular mechanisms and anti-tumoural effects of zoledronic acid in breast cancer cells 320
Genetic and molecular characterization of the human osteosarcoma 3AB-OS cancer stem cell line: a possible model for studying osteosarcoma origin and stemness. 302
EGF Induces STAT3-Dependent VEGF Expression in HT-29 colon cancer cells 290
EFFECT OF miR-21, miR-182 AND let-7i ON TSP-1 EXPRESSION IN COLON CANCER CELL LINE 288
Analysis of germline gene copy number variants of patients with sporadic pancreatic adenocarcinoma reveals specific variations 286
Breast cancer genome-wide association studies: there is strength in numbers 279
BRCA1 and BRCA2 germline mutations in sicilian breast and/or ovarian cancer families and their association with familial profiles 268
BRCA1 and BRCA2 variants of uncertain clinical significance and their implications for genetic counseling 264
The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies 253
Effects of PPARγ agonists on the expression of leptin and vascular endothelial growth factor in breast cancer cells. 250
HIF-1 is involved in the negative regulation of AURKA expression in breast cancer cell lines under hypoxic conditions 247
VUS variants in BRCA genes of hereditary breast/ovarian cancer 239
MicroRNAs in colorectal cancer stem cells: new regulators of cancer stemness? 236
Downregulated expression of Cdc25A gene in MCF-7 breast cancer cell 229
BRCA1/2 pathogenic variants in triple-negative versus luminal-like breast cancers: genotype–phenotype correlation in a cohort of 531 patients 226
A “lymphocyte microrna signature” as predictive biomarker of immunotherapy response and plasma pd-1/pd-l1 expression levels in patients with metastatic renal cell carcinoma: Pointing towards epigenetic reprogramming 218
Gene signatures in CRC and liver metastasis 213
Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2 211
Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC) 197
Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy? 191
the proximal leptin gene promoter is regulated by ppar gamma agonist in MCF-7 and MDA-MB-231 breast cancer cells 176
Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors: Still looking through a dirty glass window? 176
Potential miRNAs involved in molecular pathways mediating the anticancer effects of short term starvation in breast cancer cells treated with doxorubicin 174
MUTYH-associated tumor syndrome: The other face of MAP 172
POLE, POLD1, and NTHL1: the last but not the least hereditary cancer-predisposing genes 166
Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge 162
Low plasma PD-L1 levels, early tumor onset and absence of peritoneal carcinomatosis improve prognosis of women with advanced high-grade serous ovarian cancer 154
Potential agnostic role of BRCA alterations in patients with several solid tumors: One for all, all for one? 154
Challenges and advances for the treatment of renal cancer patients with brain metastases: From immunological background to upcoming clinical evidence on immune-checkpoint inhibitors 154
Can the plasma PD-1 levels predict the presence and efficiency of tumor-infiltrating lymphocytes in metastatic melanoma patients? 147
Can the tumor-agnostic evaluation of MSI/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors? 146
Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome 143
The Evolving Scenario in the Assessment of Radiological Response for Hepatocellular Carcinoma in the Era of Immunotherapy: Strengths and Weaknesses of Surrogate Endpoints 140
Impact of Different Selection Approaches for Identifying Lynch Syndrome-Related Colorectal Cancer Patients: Unity Is Strength 139
Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer? 133
BRCA-associated hereditary male cancers: can gender affect the prevalence and spectrum of germline pathogenic variants? 133
Prognostic role of plasma pd‐1, pd‐l1, pan‐btn3as and btn3a1 in patients affected by metastatic gastrointestinal stromal tumors: Can immune checkpoints act as a sentinel for short‐term survival? 129
Clinical relevance of exosome-derived microRNAs in Ovarian Cancer: Looking for new tumor biological fingerprints 124
HIF-1a induces downregulated expression of Aurora A in breast cancer cell lines 121
Scientific Communication and oncology – "The bridge between knowledge and patients" 118
Prognostic and Predictive Role of Tumor-Infiltrating Lymphocytes (TILs) in Ovarian Cancer 113
Impact of margin status on long-term results of liver resection for hepatocellular carcinoma: single-center time-to-recurrence analysis 110
Monoclonal antibodies for the treatment of non-hematological tumors: a safety review 105
POLE-mutated endometrial cancer: new perspectives on the horizon? 75
Totale 8.371
Categoria #
all - tutte 28.796
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.796


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202158 0 0 0 0 0 0 0 0 0 0 0 58
2021/2022495 30 80 17 15 38 27 21 20 50 64 56 77
2022/2023734 75 143 16 102 83 101 29 49 78 9 33 16
2023/2024458 20 35 27 32 31 92 48 71 5 30 8 59
2024/20251.255 14 83 107 68 72 55 185 114 48 173 144 192
2025/20263.506 319 119 195 331 387 584 499 343 259 334 102 34
Totale 8.371